Validated in prostate biopsy and radical prostatectomy samples.

“Study indicates that this prognostic gene signature is robust and reproducible, and is analytically validated for use on [formalin-fixed, paraffin-embedded] prostate biopsy and radical prostatectomy samples.”

Warf MB, Reid JE, Brown KL, et al. Analytical validation of a cell cycle progression signature used as a prognostic marker in prostate cancer. J Mol Biomark Diagn 2015 Sep; 9(9):901-10.

Learn More View Article